Form 4 for CI Cigna
Accepted 2021-09-02 00:00:00 ET · period of report 2021-08-31 · accession 0001225208-21-011986 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-02 | 2021-08-31 | CI | ZARCONE DONNA F | Dir | A - Grant | $0.00 | +224 | 26.4K | +0.9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.01 Par Value | 2021-08-31 | A | A | 224 | $0.00 | 26,426 | D | — | — | (F1) The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 34 and 107 of Cigna's proxy statement filed with the SEC on March 19, 2021. |